Tumor Response Manufacturers, Suppliers & Companies
-
Manufacturerbased in West Chester, PENNSYLVANIA (USA)
MTTI is a Clinical Stage Company; Transforming the lives of patients burdened with severe and life-threatening diseases. Advancing selective radiotherapeutics, EBTATE targeting neuroendocrine tumors, EBRGD for non-small cell lung cancer and ...
-
Manufacturerbased in Mountain View, CALIFORNIA (USA)
iPSCs- a revolutionary discovery with untapped potential. We are dedicated to revolutionizing medical treatment and prevention of cancer and other diseases by harnessing the unlimited immunotherapeutic potential of induced pluripotent stem cells ...
-
Manufacturerbased in Boston, MASSACHUSETTS (USA)
We harness the natural power of the lymph nodes to generate enhanced immune responses against tumors. Our science is defining the future of immunotherapy, with the goal of giving patients who are battling cancer their best possible outcome. We’re ...
Elicio - Model ELI-002 - mKRAS Cancer Vaccine
-cell response, including both CD4+ and CD8+ populations, that correlates with tumor biomarker responses, potentially leading to improved clinical ...
CONTACT SUPPLIER -
Manufacturerbased in Marseille Cedex 9, FRANCE
Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. Our ...
Biomarker Services
From our proprietary biomarkers, our innovated assays solutions, our unique data analysis platforms and our CDx development capabilities, we offer a comprehensive family of biomarker services that enhance your insight into the tumor ...
CONTACT SUPPLIER -
Manufacturerbased in Menlo Park, CALIFORNIA (USA)
Adicet is a biotechnology company engaged in the development of first-in-class off-the-shelf allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet has developed a proprietary cell platform process to activate, engineer and ...
-
Manufacturerbased in San Diego, CALIFORNIA (USA)
Fate Therapeutics (Nasdaq: FATE) is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer. We believe that better cell therapies start with better cells. To ...
Model FT500 - Oncology Therapeutic Cell
. Resistance to checkpoint inhibitor therapy has been linked to impaired immune cell infiltration into the tumor, impaired cytokine response, and deficiencies in antigen presentation including altered expression of ...
CONTACT SUPPLIER -
Manufacturerbased in Groningen, NETHERLANDS
ViciniVax is a Dutch clinical stage biopharmaceutical company. It is a spin-off from the University Medical Center Groningen, the Netherlands, developing therapeutic cancer vaccines. Our first product candidate Vvax001, a therapeutic cancer vaccine ...
-
Manufacturerbased in Waltham, MASSACHUSETTS (USA)
PrismRA is a molecular signature response classifier (MSRC) that uses gene expression features, clinical features and anti-cyclic citrullinated protein (anti-CCP) antibody to detect a signature of non-response to tumor necrosis factor-a inhibitors ...
-
Manufacturerbased in New York, NEW YORK (USA)
IN8bio was founded in 2016 with the mission of developing novel therapies to address cancer. The company is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T-cell product ...
DeltEx DRI - Model INB-200 - Autologous Gamma-Delta T Cell Product
-of-care to drive improved anti-tumor response. The Phase 1 repeat dose escalation clinical trial of INB-200 is being conducted at the O’Neal Comprehensive Cancer Center at the University of Alabama at ...
CONTACT SUPPLIER -
Manufacturerbased in Seattle, WASHINGTON (USA)
Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative ADAPTIR™ and ADAPTIR-FLEX platform technologies to create therapeutic candidates designed to improve outcomes for ...
Aptevo - Model APVO603 - Dual Agonist Bispecific Antibody
, potentially leading to more robust anti-tumor ...
CONTACT SUPPLIER -
Manufacturerbased in Berlin, GERMANY
T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer. The company is initially focused on T cell receptor (TCR) engineered T cell therapies (TCR-Ts), a promising modality that holds the ...
-
Manufacturerbased in Cambridge, MASSACHUSETTS (USA)
At Rubius Therapeutics, we are ushering in a new era in cellular medicine—an era in which we aim to transform the treatment of cancer and autoimmune diseases. Built upon the discoveries of Professors Harvey Lodish and Hidde Ploegh of the Whitehead ...
Model RTX-224 - Allogeneic Cellular Therapy
to activate and expand NK cells. It is expected to produce a broad and potent anti-tumor T cell response, an innate immune response and have anti-tumor activity in those ...
CONTACT SUPPLIER -
Manufacturerbased in Baldham, GERMANY
ORYX’ development strategy bridges the gap between academic research and the pharmaceutical industry for new cancer therapies. Today, the company is developing three clinical cancer immunotherapy projects in indications with high unmet medical need. ...
VicOryx - Model p16 - Therapeutic Vaccine
The human cyclin-dependent kinase inhibitor p16INK4a is a tumor antigen expressed in various cancers, including lung and breast cancer. In normal cells, p16INK4a is rarely expressed and leads to immediate senescence. In all cancers ...
CONTACT SUPPLIER -
Technologybased in Paris, FRANCE
Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections and cancer. As a clinical-stage company, Abivax leverages its immune enhancing and ...
Model ABX196 - Hepatocellular Cancer
ABX196 has been developed as a synthetic agonist of iNKT cells from a proprietary platform technology that identifies cells with immune enhancing potential in cancer ...
CONTACT SUPPLIER -
Manufacturerbased in Stockholm, SWEDEN
As a leading innovator of precision radiation therapy solutions, Elekta is committed to ensuring that every patient has access to the best cancer care possible. At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical ...
Elekta Unity - Model MR/RT - Magnetic Resonance Radiation Therapy
Elekta Unity is our ground-breaking MR-Linac. It brings together diagnostic quality MR imaging with a linear accelerator to deliver unprecedented visibility and precision. The system’s continuous, rich and timely insights into motion and ...
CONTACT SUPPLIER -
Technologybased in Cambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
Sumitomo - Immunotherapeutic Cancer Vaccines
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most cancer vaccines ...
CONTACT SUPPLIER -
Manufacturerbased in Seoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
Research Services
The AlphaLiquid® platform is being widely applied in translational research to empower our understanding of tumor evolution, response to therapy and resistance mechanisms, as well as to provide insights on the ...
CONTACT SUPPLIER -
Manufacturerbased in Raleigh, NORTH CAROLINA (USA)
Kaio's strategy is to develop and in-license technologies and therapies that enable the body’s own immune system to work more efficiently. The goal is to improve clinical outcomes for patients, increase the number and efficacy of therapeutic options ...
Kaio Therapy - Immune Activation Heat Therapy Technology
Kaio Therapy's Immune Activation Heat Therapy is a novel hyperthermia system that delivers precisely controlled heat at the cellular level within a tumor. Because Kaio’s IAHT elegantly induces necrosis while activating a ...
CONTACT SUPPLIER -
Manufacturerbased in San Diego, CALIFORNIA (USA)
Brooklyn ImmunoTherapeutics (BTX) is a clinical-stage biopharmaceutical company committed to creating a world where patients and families with high unmet medical needs have access to effective treatments. We are pioneers in using the latest ...
Human Derived Mixed Cytokines
Why human derived? Brooklyn has developed a powerful method to create complex cytokine mixtures derived from a human source. Cytokines are powerful immune factors that play an essential role in T cell signaling, activation, proliferation, and ...
CONTACT SUPPLIER -
Technologybased in Copenhagen V, DENMARK
Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. We are led by an experienced ...
Genmab DuoBody - Model PD-L1x4-1BB (GEN1046) - Proprietary Bispecific Antibody
to elicit an anti-tumor immune response by simultaneous and complementary PD-L1 blockade and conditional 4-1BB stimulation, using inert DuoBody IgG1 antibody ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you